share_log

长药控股(300391.SZ):上半年净亏损1.53亿元

Changjiang Pharmaceutical Group (300391.SZ): The net loss in the first half of the year was 0.153 billion yuan.

Gelonghui Finance ·  Aug 29, 2024 13:01

Changjiang Pharmaceutical Group (300391.SZ) announced its 2024 semi-annual report, with revenue for the reporting period of 73.6537 million yuan, a year-on-year decrease of 84.53%; net income attributable to shareholders of listed companies was -0.153 billion yuan, with a widened year-on-year loss; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was -0.15 billion yuan; basic earnings per share was -0.4355 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 336

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.